Authors: Touloukian, CE Leitner, WW Robbins, PF Rosenberg, SA Restifo, NP

Citation: Ce. Touloukian et al., Mining the melanosome for tumor vaccine targets: P. polypeptide is a noveltumor-associated, CANCER RES, 61(22), 2001, pp. 8100-8104

Authors: Zeng, G Touloukian, CE Wang, X Restifo, NP Rosenberg, SA Wang, RF

Citation: G. Zeng et al., Identification of CD4(+) T cell epitopes from NY-ESO-1 presented by HLA-DRmolecules, J IMMUNOL, 165(2), 2000, pp. 1153-1159

Authors: Touloukian, CE Leitner, WW Topalian, SL Li, YF Robbins, PF Rosenberg, SA Restifo, NP

Citation: Ce. Touloukian et al., Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice, J IMMUNOL, 164(7), 2000, pp. 3535-3542

Authors: Touloukian, CE Rosenberg, SA

Citation: Ce. Touloukian et Sa. Rosenberg, A survey of treatments used in patients with metastatic melanoma: Analysisof 189 patients referred to the National Cancer Institute, CA J SCI AM, 5(5), 1999, pp. 269-274

Authors: Overwijk, WW Lee, DS Surman, DR Irvine, KR Touloukian, CE Chan, CC Carroll, MW Moss, B Rosenberg, SA Restifo, NP

Citation: Ww. Overwijk et al., Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4(+) T lymphocytes, P NAS US, 96(6), 1999, pp. 2982-2987

Authors: Irvine, KR Parkhurst, MR Shulman, EP Tupesis, JP Custer, M Touloukian, CE Robbins, PF Yafal, AG Greenhalgh, P Sutmuller, RPM Offringa, R Rosenberg, SA Restifo, NP

Citation: Kr. Irvine et al., Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens, CANCER RES, 59(11), 1999, pp. 2536-2540